Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Matthew S. Kelly

High Impact

Section Chief, Infectious Diseases

Also affiliated: Cincinnati Children's Hospital Medical Center (2015–2017); Boston Children's Hospital (2011); Arkansas Children's Hospital (2025–2026); Children's Hospital of Philadelphia (2015–2020); Harvard University (2006); University of Botswana (2020–2025); Duke University (2014–2026); Dana-Farber Cancer Institute (2013); Duke Medical Center (2014–2026); Penn Center for AIDS Research (2015); Duke University Hospital (2017); University of Pennsylvania (2015–2025)

COM | Peds Infectious Diseases

26 h-index 132 pubs 2,122 cited

  • Humans
  • Female
  • Male
  • Child
  • Infant
  • Microbiota
  • COVID-19
  • Child, Preschool
  • Botswana
  • SARS-CoV-2
  • Prospective Studies
  • Pneumococcal Infections
  • Infant, Newborn
  • Hematopoietic Stem Cell Transplantation
  • Adolescent

Biography and Research Information

OverviewAI-generated summary

Matthew S. Kelly's research focuses on infectious diseases, particularly in pediatric populations and specific geographical contexts. He has investigated the nasopharyngeal microbiota of children with respiratory infections in Botswana, contributing to understanding microbial communities in diverse environments. His work also includes studying invasive candidiasis in premature infants and the impact of postnatal cytomegalovirus infection on very low birth weight infants, examining outcomes such as hearing, growth, and bronchopulmonary dysplasia.

Kelly has also explored broader aspects of viral infections, including dysregulated transcriptional responses to SARS-CoV-2. His research interests extend to the intersection of microbiota and disease, with publications addressing the mycobiome in pancreatic cancer and the role of anaerobic antibiotics in graft-versus-host disease after hematopoietic stem cell transplantation. He leads a research group and is recognized as a highly cited researcher, with a h-index of 26 and over 2,100 citations across his 139 publications.

Metrics

  • h-index: 26
  • Publications: 132
  • Citations: 2,122

Positions

  • Section Chief, Infectious Diseases 2025–present
    University of Arkansas for Medical Sciences COM | Peds Infectious Diseases Institutional directory
  • Professor 2025–present
    Arkansas Children's Hospital General Pediatrics ORCID
  • Associate Professor 2013–2025
    Duke University Pediatrics ORCID

Selected Publications

  • Health Utilities Associated with Pneumococcal Diseases in Children and Adults: A Targeted Literature Review and Meta-analysis (2026)
    PharmacoEconomics - Open DOI OpenAlex
  • Early life factors documented in electronic health records predict recurrent acute otitis media (2026)
    medRxiv DOI OpenAlex
  • Indirect Effects in Health Economic Models of Vaccines: Should We Include Them, and How Do We Model Them? (2026)
    Applied Health Economics and Health Policy 1 citation DOI OpenAlex
  • P-484. Global Economic Burden Of Pneumococcal Disease In Children — Lessons Learned From Economic Evaluations Of Pneumococcal Vaccines (2026)
    Open Forum Infectious Diseases DOI OpenAlex
  • Indirect comparison of the immunogenicity of 15-valent and 20-valent pneumococcal conjugate vaccines in children using a 2+1 schedule (2025)
    Expert Review of Vaccines 3 citations DOI OpenAlex
  • Pediatric T cell and B cell responses to SARS-CoV-2 infection (2025)
    JCI Insight 2 citations DOI OpenAlex
  • Alterations of the Upper Respiratory Microbiome Among Children Living With HIV Infection in Botswana (2025)
    The Journal of Infectious Diseases DOI OpenAlex
  • Corynebacterium rhinophilum sp. nov. isolated from the human upper respiratory tract (2025)
    INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

63 Collaborators 33 Institutions 3 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics